Immunome

Immunome

Immunome

Immunome is developing first-in-class therapeutics to change the way we treat cancer.
Founded
2008
Raised
$12.2M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$7,200,000
Venture capital (Series A) - 2016
$5,000,000
Venture capital (Series A) - 2016
Team Size
1–10
Employees
$7,200,000 Venture capital (Series A)
FierceBiotech , vcaonline

MIT spinout bumps up Series A to $12M+ for novel I/O discovery

Funding Health